Tobacco use in bipolar disorder.
Tobacco use in mental health in general and bipolar disorder in particular remains disproportionally common, despite declining smoking rates in the community. Furthermore, interactions between tobacco use and mental health have been shown, indicating the outcomes for those with mental health disorders are impacted by tobacco use. Factors need to be explored and addressed to improve outcomes for those with these disorders and target specific interventions for people with psychiatric illness to cease tobacco smoking. In the context of bipolar disorder, this review explores; the effects of tobacco smoking on symptoms, quality of life, suicidal behavior, the biological interactions between tobacco use and bipolar disorder, the interactions between tobacco smoking and psychiatric medications, rates and factors surrounding tobacco smoking cessation in bipolar disorder and suggests potential directions for research and clinical translation. The importance of this review is to bring together the current understanding of tobacco use in bipolar disorder to highlight the need for specific intervention.
Department of Applied Sciences, RMIT, Bundoora.
Daniel
D
Thomson
IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, Geelong.|Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Australia.|Department of Psychiatry, University of Melbourne, Parkville, Australia.
Michael
M
Berk
IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, Geelong.|Department of Psychiatry, University of Melbourne, Parkville, Australia.
Seetal
S
Dodd
Orygen Youth Health Research Centre, Centre for Youth Mental Health, University of Melbourne, Victoria, Australia.|Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Victoria, Australia.|Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Maranon, CIBERSAM, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.
Marta
M
Rapado-Castro
IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, Geelong.
Shae E
SE
Quirk
Research Unit, Mental Health Services, Region of Southern Denmark, Esbjerg, Denmark.
Pernille K
PK
Ellegaard
Centre for Mental Health and Wellbeing Research, School of Psychology, Deakin University, Burwood, Australia.
Lesley
L
Berk
IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, Geelong.|Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Australia.|Department of Psychiatry, University of Melbourne, Parkville, Australia.
Olivia M
OM
Dean
Bipolar disorder; Psychotropic drugs; Quality of life; Smoking; Smoking cessation